Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1962 1
1963 1
1965 1
1967 1
1969 2
1971 1
1972 4
1973 1
1974 2
1975 1
1976 2
1977 2
1979 1
1980 2
1981 7
1982 2
1983 3
1984 3
1986 1
1987 1
1988 4
1989 6
1990 23
1991 16
1992 21
1993 5
1994 19
1995 7
1996 9
1997 10
1998 13
1999 13
2000 26
2001 20
2002 24
2003 21
2004 37
2005 44
2006 44
2007 39
2008 36
2009 42
2010 48
2011 59
2012 57
2013 66
2014 64
2015 77
2016 80
2017 95
2018 110
2019 126
2020 162
2021 175
2022 164
2023 145
2024 179
2025 72

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,957 results

Results by year

Filters applied: . Clear all
Page 1
ALK-rearrangement in non-small-cell lung cancer (NSCLC).
Du X, Shao Y, Qin HF, Tai YH, Gao HJ. Du X, et al. Among authors: tai yh. Thorac Cancer. 2018 Apr;9(4):423-430. doi: 10.1111/1759-7714.12613. Epub 2018 Feb 28. Thorac Cancer. 2018. PMID: 29488330 Free PMC article. Review.
Bortezomib induces anti-multiple myeloma immune response mediated by cGAS/STING pathway activation.
Gulla A, Morelli E, Samur MK, Botta C, Hideshima T, Bianchi G, Fulciniti M, Malvestiti S, Prabhala RH, Talluri S, Wen K, Tai YT, Richardson PG, Chauhan D, Sewastianik T, Carrasco RD, Munshi NC, Anderson KC. Gulla A, et al. Among authors: tai yt. Blood Cancer Discov. 2021 Sep;2(5):468-483. doi: 10.1158/2643-3230.BCD-21-0047. Epub 2021 Apr 23. Blood Cancer Discov. 2021. PMID: 34568832 Free PMC article.
Lysosomal dysfunction and inflammatory sterol metabolism in pulmonary arterial hypertension.
Harvey LD, Alotaibi M, Tai YY, Tang Y, Kim HJ, Kelly NJ, Sun W, Woodcock CC, Arshad S, Culley MK, El Khoury W, Xie R, Al Aaraj Y, Zhao J, Hafeez N, Rao RJ, Jiang S, Negi V, Kirillova A, Perk D, Watson AM, St Croix CM, Stolz DB, Lee JY, Cheng MH, Zhang M, Detmer S, Guzman E, Manan RS, Saggar R, Haley KJ, Waxman AB, Okawa S, Schwantes-An TH, Pauciulo MW, Wang B, Webb A, Chauvet C, Anderson DG, Nichols WC, Desai AA, Lafyatis R, Nouraie SM, Wu H, McDonald JG, Cheng S, Bahar I, Bertero T, Benza RL, Jain M, Chan SY. Harvey LD, et al. Among authors: tai yy. Science. 2025 Jan 24;387(6732):eadn7277. doi: 10.1126/science.adn7277. Epub 2025 Jan 24. Science. 2025. PMID: 39847635
Ubiquitin receptor PSMD4/Rpn10 is a novel therapeutic target in multiple myeloma.
Du T, Song Y, Ray A, Wan X, Yao Y, Samur MK, Shen C, Penailillo J, Sewastianik T, Tai YT, Fulciniti M, Munshi NC, Wu H, Carrasco RD, Chauhan D, Anderson KC. Du T, et al. Among authors: tai yt. Blood. 2023 May 25;141(21):2599-2614. doi: 10.1182/blood.2022017897. Blood. 2023. PMID: 36630605 Free PMC article.
Daratumumab granted breakthrough drug status.
Laubach JP, Tai YT, Richardson PG, Anderson KC. Laubach JP, et al. Among authors: tai yt. Expert Opin Investig Drugs. 2014 Apr;23(4):445-52. doi: 10.1517/13543784.2014.889681. Epub 2014 Feb 20. Expert Opin Investig Drugs. 2014. PMID: 24555809
FLT1 activation in cancer cells promotes PARP-inhibitor resistance in breast cancer.
Tai Y, Chow A, Han S, Coker C, Ma W, Gu Y, Estrada Navarro V, Kandpal M, Hibshoosh H, Kalinsky K, Manova-Todorova K, Safonov A, Walsh EM, Robson M, Norton L, Baer R, Merghoub T, Biswas AK, Acharyya S. Tai Y, et al. EMBO Mol Med. 2024 Aug;16(8):1957-1980. doi: 10.1038/s44321-024-00094-2. Epub 2024 Jul 2. EMBO Mol Med. 2024. PMID: 38956205 Free PMC article.
1,957 results